These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 31269274)

  • 21. Intensification of antihyperglycemic therapy among patients with incident diabetes: a Surveillance Prevention and Management of Diabetes Mellitus (SUPREME-DM) study.
    Raebel MA; Ellis JL; Schroeder EB; Xu S; O'Connor PJ; Segal JB; Butler MG; Schmittdiel JA; Kirchner HL; Goodrich GK; Lawrence JM; Nichols GA; Newton KM; Pathak RD; Steiner JF
    Pharmacoepidemiol Drug Saf; 2014 Jul; 23(7):699-710. PubMed ID: 24639086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous control of intermediate diabetes outcomes among Veterans Affairs primary care patients.
    Jackson GL; Edelman D; Weinberger M
    J Gen Intern Med; 2006 Oct; 21(10):1050-6. PubMed ID: 16970554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of diabetes control on mortality by race in a national cohort of veterans.
    Hunt KJ; Gebregziabher M; Lynch CP; Echols C; Mauldin PD; Egede LE
    Ann Epidemiol; 2013 Feb; 23(2):74-9. PubMed ID: 23238350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longitudinal differences in glycemic control by race/ethnicity among veterans with type 2 diabetes.
    Egede LE; Mueller M; Echols CL; Gebregziabher M
    Med Care; 2010 Jun; 48(6):527-33. PubMed ID: 20473215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deintensification of Diabetes Medications among Veterans at the End of Life in VA Nursing Homes.
    Niznik JD; Hunnicutt JN; Zhao X; Mor MK; Sileanu F; Aspinall SL; Springer SP; Ersek MJ; Gellad WF; Schleiden LJ; Hanlon JT; Thorpe JM; Thorpe CT
    J Am Geriatr Soc; 2020 Apr; 68(4):736-745. PubMed ID: 32065387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paradox of glycemic management: multimorbidity, glycemic control, and high-risk medication use among adults with diabetes.
    McCoy RG; Lipska KJ; Van Houten HK; Shah ND
    BMJ Open Diabetes Res Care; 2020 Feb; 8(1):. PubMed ID: 32075810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Starting insulin therapy in patients with type 2 diabetes: effectiveness, complications, and resource utilization.
    Hayward RA; Manning WG; Kaplan SH; Wagner EH; Greenfield S
    JAMA; 1997 Nov; 278(20):1663-9. PubMed ID: 9388085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
    Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
    JAMA; 2021 Jun; 325(22):2273-2284. PubMed ID: 34077502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High hemoglobin A
    Arya S; Binney ZO; Khakharia A; Long CA; Brewster LP; Wilson PW; Jordan WD; Duwayri Y
    J Vasc Surg; 2018 Jan; 67(1):217-228.e1. PubMed ID: 28844470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of patients' risks and preferences on health gains with plasma glucose level lowering in type 2 diabetes mellitus.
    Vijan S; Sussman JB; Yudkin JS; Hayward RA
    JAMA Intern Med; 2014 Aug; 174(8):1227-34. PubMed ID: 24979148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of incident dementia following metformin initiation compared with noninitiation or delay of antidiabetic medication therapy.
    Salas J; Morley JE; Scherrer JF; Floyd JS; Farr SA; Zubatsky M; Barthold D; Dublin S
    Pharmacoepidemiol Drug Saf; 2020 Jun; 29(6):623-634. PubMed ID: 32363681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fracture risk in patients with type 2 diabetes aged ≥50 years related to HbA1c, acute complications, BMI and SGLT2i-use in the DPV registry.
    Eckert AJ; Mader JK; Altmeier M; Mühldorfer S; Gillessen A; Dallmeier D; Shah VN; Heyer C; Hartmann B; Holl RW
    J Diabetes Complications; 2020 Oct; 34(10):107664. PubMed ID: 32624333
    [No Abstract]   [Full Text] [Related]  

  • 33. Association between glycemic control and cardiovascular events in older Japanese adults with diabetes mellitus: An analysis of the Japanese medical administrative database.
    Yokote K; Suzuki R; Gouda M; Iijima H; Yamazaki A; Inagaki M
    J Diabetes Investig; 2021 Nov; 12(11):2036-2045. PubMed ID: 33988907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetes treatment intensification and associated changes in HbA1c and body mass index: a cohort study.
    Roumie CL; Greevy RA; Grijalva CG; Hung AM; Liu X; Griffin MR
    BMC Endocr Disord; 2016 Jun; 16(1):32. PubMed ID: 27255309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycemic control and diabetes complications across health status categories in older adults treated with insulin or insulin secretagogues: The Diabetes & Aging Study.
    Lipska KJ; Huang ES; Liu JY; Parker MM; Laiteerapong N; Grant RW; Moffet HH; Karter AJ
    J Am Geriatr Soc; 2023 Dec; 71(12):3692-3700. PubMed ID: 37638777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The feasibility of intensive insulin management in non-insulin-dependent diabetes mellitus. Implications of the Veterans Affairs Cooperative Study on Glycemic Control and Complications in NIDDM.
    Colwell JA
    Ann Intern Med; 1996 Jan; 124(1 Pt 2):131-5. PubMed ID: 8554205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improvement of glycemic control in type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials.
    Monami M; Candido R; Pintaudi B; Targher G; Mannucci E;
    Nutr Metab Cardiovasc Dis; 2021 Aug; 31(9):2539-2546. PubMed ID: 34158243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Insulin Glargine Up-titration vs Insulin Degludec/Liraglutide on Glycated Hemoglobin Levels in Patients With Uncontrolled Type 2 Diabetes: The DUAL V Randomized Clinical Trial.
    Lingvay I; Pérez Manghi F; García-Hernández P; Norwood P; Lehmann L; Tarp-Johansen MJ; Buse JB;
    JAMA; 2016 Mar; 315(9):898-907. PubMed ID: 26934259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Initial Presentation of Type 2 Diabetes in Adolescents Predicts Durability of Successful Treatment with Metformin Monotherapy: Insights from the Pediatric Diabetes Consortium T2D Registry.
    Bacha F; Cheng P; Gal RL; Kollman C; Tamborlane WV; Klingensmith GJ; Manseau K; Wood J; Beck RW;
    Horm Res Paediatr; 2018; 89(1):47-55. PubMed ID: 29131017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
    Weng J
    J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.